Research relies on replication: Different teams need to make the same conclusion multiple times before a consensus is reached ...

The Global Gene Expression Market is estimated to be valued at USD 16.56 Bn in 2025 and is expected to reach USD 23.61 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to ...

Natural Gas Services Group, Inc. stands out with strong growth, solid financials, and 25-30% stock upside. Click here to read ...

The Vietnam Academy of Science and Technology (VAST) organised a ceremony in Hanoi on December 11 to announce DNA ...

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, ...

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...

Different teams need to make the same conclusion multiple times before a consensus is reached and the finding can be ...

Accelerated sequencing technologies, AI-enabled analytics, newborn screening expansion, and government-backed genomic initiatives fuel rapid growth across North America, Europe, and ...

Discover why Palo Alto Networks (PANW) is rated BUY after strong Q1 results, AI-focused acquisitions, and a 20% upside.

The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted ...

Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key presentations at the conference highlighted ...

The SERENA-6 trial shows a 54% reduced risk of death with camizestrant, with a median PFS of 16.6 months versus 9.2 months ...